Sharp Therapeutics Corp.
SHRXF
$3.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.92M | -5.29M | -3.26M | -4.09M | -4.91M |
| Total Depreciation and Amortization | 99.70K | 85.00K | 100.30K | 101.60K | 102.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.76M | 849.10K | -515.10K | 767.70K | 2.05M |
| Change in Net Operating Assets | -522.60K | -86.00K | 30.60K | 291.10K | 551.60K |
| Cash from Operations | -5.10M | -4.44M | -3.64M | -2.93M | -2.21M |
| Capital Expenditure | 0.00 | 16.60K | -14.50K | -14.50K | -14.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.20K | 5.20K | 5.20K | 2.60K | -- |
| Cash from Investing | 5.20K | 21.80K | -9.30K | -11.90K | -14.50K |
| Total Debt Issued | 950.00K | 2.20M | 2.20M | 1.08M | -32.20K |
| Total Debt Repaid | -436.80K | -436.80K | -436.80K | -318.40K | -200.00K |
| Issuance of Common Stock | 7.45M | 4.96M | 5.46M | 4.17M | 2.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.60K | 29.60K | 29.60K | 14.80K | -- |
| Cash from Financing | 7.99M | 6.76M | 7.26M | 4.95M | 2.65M |
| Foreign Exchange rate Adjustments | 25.90K | -20.00K | 6.00K | 3.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -500.00K | -500.00K | -500.00K | -500.00K |
| Net Change in Cash | 2.92M | 1.82M | 3.11M | 1.52M | -74.00K |